Using simultaneous amplification and testing method for evaluating the treatment outcome of pulmonary tuberculosis

Area of Science:

• Microbiology
• Infectious Diseases
• Medical Diagnostics

Background:

• Tuberculosis (TB) treatment monitoring is crucial for patient outcomes.
• Current methods like BACTEC MGIT 960 culture assays can be time-consuming.
• There is a need for more efficient diagnostic tools to assess anti-TB treatment response.

Purpose of the Study:

• To evaluate the utility of the Simultaneous Amplification and Testing (SAT-TB) method for monitoring anti-TB treatment response.
• To compare the diagnostic performance of SAT-TB with smear fluorescence microscopy (FM) and BACTEC MGIT 960 culture assays.

Main Methods:

• Serial sputum specimens were collected from 377 active pulmonary tuberculosis patients.
• Specimens were analyzed using the AmpSure assay (SAT-TB), smear FM, and BACTEC MGIT 960 culture at multiple time points.
• Data were analyzed to compare detection rates and identify treatment failures.

Main Results:

• SAT-TB demonstrated significantly higher detection rates than sputum FM at 2 weeks (78.21% vs 51.07%) and 2 months (73.25% vs 50.32%) of treatment.
• At 5 months, SAT-TB correctly identified 92.31% of patients with culture-confirmed treatment failure, compared to 58.46% for sputum FM.
• SAT-TB results can be obtained independently of BACTEC MGIT 960 results.

Conclusions:

• The SAT-TB method is a valuable tool for monitoring anti-TB treatment response.
• SAT-TB offers improved sensitivity and speed compared to sputum FM.
• The assay aids in the early detection of treatment failures, allowing for timely intervention.